Home › Funds › Avoro Capital Advisors LLC › GPCR
Avoro Capital Advisors LLC position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
Avoro Capital Advisors LLC reported holding 6,555,555 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$205.0M, representing 2.12% of its reported portfolio and ranking #11 among its reported holdings. Avoro Capital Advisors LLC has disclosed GPCR holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Avoro Capital Advisors LLC's GPCR position evolved
Avoro Capital Advisors LLC first disclosed a stake in GPCR in Q3 2023 at 1,000,000 shares (US$50.4M). The position peaked in Q4 2025 at 6,555,555 shares, worth US$455.9M. Across 7 filings, Avoro Capital Advisors LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 6,555,555 shares valued at US$205.0M. Notable position changes include a 133% increase in Q4 2023 (shares rose 5% over the following quarter), a 2522% increase in Q4 2025 (shares fell 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.00M | $50.42M | New |
| Q4 2023 | 2.33M | $95.11M | Add |
| Q3 2025 | 250.00K | $2.24M | New |
| Q4 2025 | 6.56M | $455.94M | Add |
| Q1 2026 | 6.56M | $315.98M | Hold |
| Q2 2026 | 6.56M | $351.84M | Hold |
| Q3 2026 | 6.56M | $204.99M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 25 other funds we track also report a position in GPCR — the largest reported positions include BVF INC/IL (US$180.7M), Deep Track Capital, LP (US$156.3M), ORBIMED ADVISORS LLC (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- Deep Track Capital, LP 5.00M sh · $156.35M · Q3 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- RTW INVESTMENTS, LP 2.28M sh · $71.36M · Q3 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Paradigm Biocapital Advisors LP 1.30M sh · $40.63M · Q3 2026
- Logos Global Management LP 1.00M sh · $31.27M · Q3 2026
- Siren, L.L.C. 872.97K sh · $27.30M · Q3 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K sh · $25.02M · Q3 2026
- Rock Springs Capital Management LP 640.32K sh · $20.02M · Q3 2026
More on Avoro Capital Advisors LLC
FAQ
How long has Avoro Capital Advisors LLC held GPCR?
Avoro Capital Advisors LLC has disclosed GPCR holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
What is Avoro Capital Advisors LLC's current position in GPCR?
As of Q3 2026, Avoro Capital Advisors LLC holds 6.56M shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $204.99M, representing 2.12% of its reported portfolio and ranking #11.
Has Avoro Capital Advisors LLC been buying or selling GPCR?
In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC held unchanged its position in GPCR. The position peaked in Q4 2025 at 6.56M shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include BVF INC/IL, Deep Track Capital, LP, ORBIMED ADVISORS LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.